These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 16829685)
1. The XRCC1 -77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage. Brem R; Cox DG; Chapot B; Moullan N; Romestaing P; Gérard JP; Pisani P; Hall J Carcinogenesis; 2006 Dec; 27(12):2469-74. PubMed ID: 16829685 [TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Moullan N; Cox DG; Angèle S; Romestaing P; Gérard JP; Hall J Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1168-74. PubMed ID: 14652276 [TBL] [Abstract][Full Text] [Related]
3. A functional -77T>C polymorphism in XRCC1 is associated with risk of breast cancer. Liu L; Yuan P; Liu L; Wu C; Zhang X; Guo H; Zhong R; Xu Y; Wu J; Duan S; Rui R; Wu T; Nie S; Miao X; Lin D Breast Cancer Res Treat; 2011 Jan; 125(2):479-87. PubMed ID: 20549339 [TBL] [Abstract][Full Text] [Related]
4. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738 [TBL] [Abstract][Full Text] [Related]
5. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Angèle S; Romestaing P; Moullan N; Vuillaume M; Chapot B; Friesen M; Jongmans W; Cox DG; Pisani P; Gérard JP; Hall J Cancer Res; 2003 Dec; 63(24):8717-25. PubMed ID: 14695186 [TBL] [Abstract][Full Text] [Related]
6. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Hao B; Miao X; Li Y; Zhang X; Sun T; Liang G; Zhao Y; Zhou Y; Wang H; Chen X; Zhang L; Tan W; Wei Q; Lin D; He F Oncogene; 2006 Jun; 25(25):3613-20. PubMed ID: 16652158 [TBL] [Abstract][Full Text] [Related]
7. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Chang-Claude J; Popanda O; Tan XL; Kropp S; Helmbold I; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Schmezer P; Ambrosone CB Clin Cancer Res; 2005 Jul; 11(13):4802-9. PubMed ID: 16000577 [TBL] [Abstract][Full Text] [Related]
8. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk. Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697 [TBL] [Abstract][Full Text] [Related]
9. DNA repair gene XRCC1 polymorphisms and haplotypes in diffuse large B-cell lymphoma in a Korean population. Kim IS; Kim DC; Kim HG; Eom HS; Kong SY; Shin HJ; Hwang SH; Lee EY; Kim S; Lee GW Cancer Genet Cytogenet; 2010 Jan; 196(1):31-7. PubMed ID: 19963133 [TBL] [Abstract][Full Text] [Related]
10. Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women. Yin J; Vogel U; Ma Y; Qi R; Wang H Cancer Genet Cytogenet; 2009 Jan; 188(1):26-31. PubMed ID: 19061777 [TBL] [Abstract][Full Text] [Related]
11. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population. Srivastava A; Srivastava K; Pandey SN; Choudhuri G; Mittal B Ann Surg Oncol; 2009 Jun; 16(6):1695-703. PubMed ID: 19266243 [TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in three base excision repair genes and breast cancer risk in Thai women. Sangrajrang S; Schmezer P; Burkholder I; Waas P; Boffetta P; Brennan P; Bartsch H; Wiangnon S; Popanda O Breast Cancer Res Treat; 2008 Sep; 111(2):279-88. PubMed ID: 17922186 [TBL] [Abstract][Full Text] [Related]
13. XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. Pachkowski BF; Winkel S; Kubota Y; Swenberg JA; Millikan RC; Nakamura J Cancer Res; 2006 Mar; 66(5):2860-8. PubMed ID: 16510609 [TBL] [Abstract][Full Text] [Related]
14. XRCC1 polymorphism and lung cancer risk. Schneider J; Classen V; Helmig S Expert Rev Mol Diagn; 2008 Nov; 8(6):761-80. PubMed ID: 18999926 [TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia. Pakakasama S; Sirirat T; Kanchanachumpol S; Udomsubpayakul U; Mahasirimongkol S; Kitpoka P; Thithapandha A; Hongeng S Pediatr Blood Cancer; 2007 Jan; 48(1):16-20. PubMed ID: 16435384 [TBL] [Abstract][Full Text] [Related]
16. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Saadat M; Ansari-Lari M Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169 [TBL] [Abstract][Full Text] [Related]
17. A prospective study of XRCC1 haplotypes and their interaction with plasma carotenoids on breast cancer risk. Han J; Hankinson SE; De Vivo I; Spiegelman D; Tamimi RM; Mohrenweiser HW; Colditz GA; Hunter DJ Cancer Res; 2003 Dec; 63(23):8536-41. PubMed ID: 14679022 [TBL] [Abstract][Full Text] [Related]
18. Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients. Suga T; Ishikawa A; Kohda M; Otsuka Y; Yamada S; Yamamoto N; Shibamoto Y; Ogawa Y; Nomura K; Sho K; Omura M; Sekiguchi K; Kikuchi Y; Michikawa Y; Noda S; Sagara M; Ohashi J; Yoshinaga S; Mizoe J; Tsujii H; Iwakawa M; Imai T Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):685-93. PubMed ID: 17889263 [TBL] [Abstract][Full Text] [Related]
19. DNA repair capacity and acute radiotherapy adverse effects in Italian breast cancer patients. Sterpone S; Cornetta T; Padua L; Mastellone V; Giammarino D; Testa A; Tirindelli D; Cozzi R; Donato V Mutat Res; 2010 Feb; 684(1-2):43-8. PubMed ID: 19962393 [TBL] [Abstract][Full Text] [Related]
20. Significance of amino acid substitution variants of DNA repair genes in radiosusceptibility of cervical cancer patients; a pilot study. Farkasova T; Gurska S; Witkovsky V; Gabelova A Neoplasma; 2008; 55(4):330-7. PubMed ID: 18505345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]